SG10201408374WA - Therapeutic Combinations Of Theobromine And An Antihistamine - Google Patents

Therapeutic Combinations Of Theobromine And An Antihistamine

Info

Publication number
SG10201408374WA
SG10201408374WA SG10201408374WA SG10201408374WA SG10201408374WA SG 10201408374W A SG10201408374W A SG 10201408374WA SG 10201408374W A SG10201408374W A SG 10201408374WA SG 10201408374W A SG10201408374W A SG 10201408374WA SG 10201408374W A SG10201408374W A SG 10201408374WA
Authority
SG
Singapore
Prior art keywords
antihistamine
theobromine
therapeutic combinations
therapy
therapeutic
Prior art date
Application number
SG10201408374WA
Other languages
English (en)
Inventor
John Brew
Robin Mark Bannister
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of SG10201408374WA publication Critical patent/SG10201408374WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SG10201408374WA 2009-12-14 2010-12-14 Therapeutic Combinations Of Theobromine And An Antihistamine SG10201408374WA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0921803.3A GB0921803D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy

Publications (1)

Publication Number Publication Date
SG10201408374WA true SG10201408374WA (en) 2015-01-29

Family

ID=41667043

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201408374WA SG10201408374WA (en) 2009-12-14 2010-12-14 Therapeutic Combinations Of Theobromine And An Antihistamine
SG2012042495A SG181603A1 (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2012042495A SG181603A1 (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine

Country Status (18)

Country Link
EP (1) EP2512472A1 (enExample)
JP (2) JP2013513652A (enExample)
CN (1) CN102802625A (enExample)
AU (1) AU2010332495C1 (enExample)
BR (1) BR112012014159A8 (enExample)
CA (1) CA2784215A1 (enExample)
CO (1) CO6541638A2 (enExample)
GB (1) GB0921803D0 (enExample)
IL (1) IL220384A0 (enExample)
MX (1) MX2012006624A (enExample)
NZ (1) NZ600267A (enExample)
PE (1) PE20121538A1 (enExample)
PH (1) PH12012501200A1 (enExample)
RU (1) RU2012129675A (enExample)
SG (2) SG10201408374WA (enExample)
UA (1) UA105827C2 (enExample)
WO (1) WO2011073647A1 (enExample)
ZA (1) ZA201204294B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
CN103263533B (zh) * 2013-05-31 2014-11-05 杨宏伟 一种治疗咳嗽的可可碱组合物及其用途及其制剂
CN104224819B (zh) * 2014-09-18 2016-08-17 中山大学 一种柚皮苷与盐酸左西替利嗪药物组合物及其制剂
CN104188998A (zh) * 2014-09-18 2014-12-10 中山大学 一种柚皮苷与盐酸非索非那丁药物组合物及其制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3766885D1 (en) * 1986-04-17 1991-02-07 Alza Corp Chlorpheniramine therapie.
HUP9700654A2 (hu) 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
JPH10316568A (ja) * 1997-05-13 1998-12-02 Taisho Pharmaceut Co Ltd 医薬組成物
JP2003012514A (ja) * 2001-07-02 2003-01-15 Taisho Pharmaceut Co Ltd 医薬組成物
JP2003128549A (ja) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
CA2682730A1 (en) * 2007-04-11 2008-10-23 Alcon Research, Ltd. Use of an inhibitor of tnf.alpha. plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis

Also Published As

Publication number Publication date
GB0921803D0 (en) 2010-01-27
PH12012501200A1 (en) 2012-11-26
IL220384A0 (en) 2012-08-30
ZA201204294B (en) 2013-02-27
CN102802625A (zh) 2012-11-28
EP2512472A1 (en) 2012-10-24
CO6541638A2 (es) 2012-10-16
JP6078605B2 (ja) 2017-02-08
WO2011073647A1 (en) 2011-06-23
JP2016040280A (ja) 2016-03-24
AU2010332495A1 (en) 2012-06-21
CA2784215A1 (en) 2011-06-23
PE20121538A1 (es) 2012-12-21
RU2012129675A (ru) 2014-01-27
AU2010332495C1 (en) 2016-02-11
UA105827C2 (uk) 2014-06-25
AU2010332495B2 (en) 2015-01-22
NZ600267A (en) 2013-07-26
BR112012014159A8 (pt) 2017-12-26
SG181603A1 (en) 2012-07-30
JP2013513652A (ja) 2013-04-22
MX2012006624A (es) 2012-10-05
BR112012014159A2 (pt) 2017-08-29

Similar Documents

Publication Publication Date Title
PH12012501200A1 (en) Therapeutic combinations of theobromine and an antihistamine
TN2013000508A1 (en) Combination therapy comprising a cdk4/6 inhibitor and a pi3k inhibitor for use in the treatment of cancer
SI2069342T1 (sl) Derivati aril fenil imidazo a piridinov njihova priprava in njihova terapevtska uporaba
ZA201000075B (en) Purin derivatives for use in the treatment of fab-related diseases
IL210802A0 (en) Purin derivatives for use in the treatment of fab-related diseases
ZA201206062B (en) Aminotetraline derivatives,pharmaceutical compositions containing them,and their use in therapy
MX2012009576A (es) Formas de rifaximina y usos de la misma.
IL180872A0 (en) Substituted 8-aminoalkylthio-xanthines, and the use thereof as inhibitors of the dipeptidyl peptidase iv
AU316078S (en) Surgical tissue stimulator/locator
WO2010121164A3 (en) 1,4-benzodiazepinone compounds and their use in treating cancer
PH12013500392A1 (en) Theobromine in combination with an expectorant or a mucolytic for use in therapy
PH12012501369A1 (en) Drug combination with theobromine and its use in therapy
PH12012501203A1 (en) Combination of theobromine with a decongestant and its use for the treatment of cough
ZA201000581B (en) 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives,preparation and therapeutic use thereof
IL198481A0 (en) Pyrrole derivatives, preparation use of the same in therapy
PH12012500955A1 (en) Drug combination with theobromine and its use in therapy
TW200631584A (en) A medicament related to mirtazapine for the treatment of hot flush
WO2009103010A3 (en) Alpha-synuclein kinase
GB201108289D0 (en) Therapeutic garment and method of providing therapy using the same
UA43276U (uk) Спосіб чуприкова-таршинова лікування гіперактивності у дітей
WO2011161465A3 (en) Composition for treatment of skin
UA70710U (ru) Способ профилактики рецидивов аллергодерматозов у больных с вторичными иммунодефицитными состояниями
ECSP12011969A (es) Combinaciones terapéuticas de teobromina y una antihistamina
UA57852U (ru) Способ лечения рецидивных форм аллергодерматозов у больных c наличием вторичных иммунодефицитных состояний
HK1159603A (en) Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy